Robert Jacobs

Pharmacy and Medicine
Palo Alto, California, United States of America

Connect with the speaker?

Robert T. Jacobs (Scynexis) "Discovery and Pre-Clinical Development of SCYX-7158 (AN 5568), a Novel Oxaborole-6-Carboxamide with Potential for Treatment of Stage 2 Human African Trypanosomiasis".